Mizolastine-13C, d3
Mizolastine-13C, d3 is the 13C- and deuterium labeled Mizolastine.
Product Specifications
UNSPSC
12352005
Target
Histamine Receptor; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling; Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Inflammation/Immunology; Endocrinology
Solubility
10 mM in DMSO
Smiles
O=C1NC(N(C2CCN(C3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)CC2)[13C]([2H])([2H])[2H])=NC=C1
Molecular Formula
C23 13CH22D3FN6O
Molecular Weight
436.50
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.|[2]Prakash A, et al. Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria. BioDrugs. 1998 Jul;10 (1) :41-63.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
H1 Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0535708 1.0 µg DNA
CXCL12 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
MBS566949-01 0.2 mg
c-Myc (human) Recombinant monoclonal antibody (9E10) (Human IgG1 kappa)
Sign In for Pricing
View Details 
MBS566949-02 5x 0.2 mg
c-Myc (human) Recombinant monoclonal antibody (9E10) (Human IgG1 kappa)
Sign In for Pricing
View Details